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Abstract
Lymphatic filariasis (elephantiasis) is a major neglected disease caused by filarial 
nematodes including; Wuchereria bancrofti, Brugia malayi {B. malayi) and Brugia 
timori. Over 120 million individuals are infected and more than 1.3 billion people are at 
risk of infection in 81 endemic countries. Current treatments are limited, toxic and fail to 
kill adult parasites. There is a need for new target and treatments. One potential novel 
drug target for this disease is stress-activated protein kinases. It has been previously 
demonstrated in our laboratory that a B. malayi stress-activated protein kinase, Bm- 
MPK1, an ortholog of the human p38/Caenorhabditis elegans (C. elegans) PMK-1, plays 
a role in protecting B. malayi from oxidative stress. I have characterized a second, 
evolutionary conserved stress activated kinase pathway, the c-Jun N-terminal kinase 
(JNK) pathway. B. malayi expresses a single JNK kinase (Bm-JNKl) isoform which is 
highly homologous to both human and Caenorhabditis elegans (C. elegans) JNK kinases. 
In C. elegans, it has been demonstrated through genetic means that JNK plays a role in 
several responses such as heavy metal stress, heat shock, and coordination of movement. 
Using heavy metal stress as a model system, I have demonstrated that treatment of B. 
malayi parasites with human JNK inhibitors, under heavy metal stress conditions, results 
in decreased motility and viability of adult and larval forms of the parasite. Furthermore, 
I have expressed recombinant Bm-JNKl and characterized its enzymatic activity with the 
ultimate goal of screening JNK inhibitors for activity against this enzyme. These results 
define a JNK pathway in B. malayi with functions similar to those found in C. elegans.
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Introduction
Lymphatic filariasis, also known as elephantiasis, is a profoundly disfiguring and 
painful parasitic disease caused by three filarial nemotodes: Wuchereria bancrofti (W. 
bancrofti), Brugia malayi (B. malayi) and Brugia timori (B. timori). (1) Currently, there 
are more than 1.3 billion people at risk of infection, over 120 million people infected, out 
of which 40 million of people are disfigured and incapacitated by the disease. Lymphatic 
filariasis has a major social and economic impact since the millions of individual infected 
are disabled. The disease is transmitted through a mosquito vector. When mosquitoes 
take a blood meal from an infected person they ingest microfilariae (mf) which are the 
immature larval stage of the parasite. In the mosquito, the mfs develop into infectious 
third-stage larva (L3) (2). The cycle continues when the infected mosquito takes another 
blood meal and infects the host by introducing L3s. L3s, subsequently migrate to the 
lymphatic vessels and develop into adult worms which lodge in the lymphatic system 
causing lymphatic tissue remodeling and disruption of the immune system. Adult worms 
effectively evade the host immune response and can live up to 8 years. Adult female 
worms, throughout their lifespan, release millions of mfs into the blood producing up to 
10,000 mfs per day that can live up to a year. (2)
Over the last two decades there has been an expansion of filariasis research, 
which has provided new insights into the global burden of filariasis, the pathogenesis of 
filarial disease, diagnosis, and control (3). In 2000, the World Health Organization 
(WHO) established the Global Programme to Eliminate Lymphatic Filariasis (GPELF), 
which has the goal of eliminating the disease by 2020 with mass drug administration
l
(MDA). Despite some success of MDA, in order to completely eliminate this disease it 
will be essential to establish new drug targets and treatments. Current drugs used to treat 
include: albendazole, diethylcarbamazine (DEC) and Mectizan ® (ivermectin). All have 
significant toxicity associated with them making it difficult to persuade asymptomatic 
infected individuals to take these drugs due to various side effects associated with them 
(4). In addition, current treatments are only effective on mfs rather than the adult worms 
making it difficult to interrupt the cycle and in turn leading to unnecessary long-term 
treatment and financial burden.
In order to identify new therapeutic agents for the treatment of filarial disease, it 
is necessary to better understand filarial homeostasis and critical parasite biochemical 
pathways. The sequencing of the B. malayi genome has opened the way to find new drug 
targets (5). Our laboratory has recently identified a potential novel drug target in B. 
malayi. The B. malayi mitogen-activated protein kinase (MAPK), Bm-MPKl, has been 
shown to play a critical role in protecting the parasite from reactive oxygen species 
(ROS) [ref]. ROS is generated by cells of the innate immune system, which include, 
macrophages, neutrophils, eosinophils and basophil granulocytes. ROS can lead to lipid 
oxidation, protein modification and DNA damage. Bm-MPKl is an ortholog of human 
p38 stress-activated map kinase (p38) and C. elegans PMK-1, both of which play critical 
roles in protection against ROS and other stresses [6-8].
MAPKs belong to a family of evolutionarily conserved protein kinases that 
regulate cellular fates and responses to a variety of extracellular signals (9) such as 
mitogens, osmotic stress, heat shock and inflammatory cytokines. MAPKs are activated 
by tyrosine and threonine phosphorylation in response to those extracellular stimuli. In
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humans there are three known subgroups of MAPKS: the extracellular signal regulated 
kinases (ERK), the c-Jun N-terminal kinases (JNK) and p38 kinase (10). Characteristic of 
this family of protein kinases is a dual phosphorylation site within the activation loop of 
the enzyme which confers selectivity on the individual pathways. These sites are TEY for 
the ERK family, TPY for JNK, and TGY for p38. (10). MAPKs typically are part of a 
phosphorylation cascade and are activated by upstream kinases (MAPKKs). ERK is 
activated by MEK, JNK by MKK4 and MKK7 and MKK3 and MKK6 act solely as an 
activator for the p38 group (10, 11).
JNK kinases are also activated by a variety of stresses and are also involved in 
several critical biological processes such as cancer, development, apoptosis, and cell 
survival (12). C. elegans JNK1 has been shown, through genetic means, to play a 
protective role in a variety of stress responses such as heavy metal and osmotic stress (9). 
I searched for an ortholog in B. malayi to determine if this pathway is present in the 
parasite. Using inhibitors of human JNK, I have found that these inhibitors interfere with 
B. malayi responses to heavy metals. I have also identified a JNK ortholog in B. malayi 
using bioinformatic approaches and successfully expressed active enzyme. These studies 





Human JNK inhibitors: Anthra[l-9-c<7]pyrazol-6(2//)-one (SP600125, Tocris 
bioscience, Bristol, UK), A-(3-Cyano-4,5,6,7-tetrahydrobenzo[6]thienyl-2-yl)-l- 
naphthalenecarboxamide (TCS, Tocris bioscience) and N-(4-Amino-5-cyano-6- 
ethoxypyridin-2-yl)-2-(2,5-dimethoxyphenyl) acetamide (JNKi, Enzo Life Sciences, 
Farmingdale, NY) were reconstituted in 100% DMSO and stored at -20°C prior to use.
2. B. malayi culture
2.1. Parasites motility
Female adult B. malayi worms, L4, and microfilariae (mf) were obtained from the 
NIAID/NIH Filariasis Research Reagent Resource Center (FR3). Either RPMI 1640 
medium (Invitrogen, Carlsbad, Ca) or Advanced RMPI 1640 medium (Invitrogen) was 
used to maintain the parasites. Both mediums were supplemented with 100 U/mL 
Penicillin (Invitrogen), 2.5 p,g/mL Amphotericin B solution (Invitrogen) and heat 
inactivated fetal bovine serum (10% for RPMI 1640 and 5% for Advanced RPMI). 
Additionally, Advanced RPMI 1640 medium was supplemented with 25 mM HEPES and 
2 mM L-Glutamine (Invitrogen). Parasites were maintained in a 37°C humidified 
incubator with 5% CO2.
Female adult worms were separated using forceps, if necessary camel brushes 
were used as well. Adult worms were plated in 24-well plates with 2 mL of media, 1
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worm per well. Mf were counted using hemocytometer where the entire 10 pL chamber 
was counted. Mfs were plated into 96-well with each well containing 40-100 mf/100 pL. 
L4s were plated into 24-well plate with 2 mL of media, 4 to 5 L4 were used per well. 
The adult worm, mf and L4 were allowed to incubate for 24h in a 37°C humidified 
incubator with 5% CO2. After 24 hours, the parasites were scored based on their motility 
with range from 0 to 4 with 4: being highly active and coiling (eight shape); 3: moderated 
movement with minimum to no coiling (spiral shape); 2: slow movement and uncoiled 
(wave shape); 1: twitching movement mostly one end twitching (straight/flat); 0: no 
movement at all (dead). The highly active and unbroken adult worms were chosen for 
treatments. The treatment groups received JNK inhibitors: JNKi (10 pM or 5 pM), 5 pM 
TCS, and 1 pM SP600125, stress (25 pM Copper II sulfate (Q1SO4) or 0.5 mM sodium 
arsenate (Na2HAsC>4, MP Biomedicals, Solon, Ohio) with JNK inhibitors, 0.1% DMSO 
(control) or stress (CUSO4 or sodium arsenate) alone as a vehicle control. Adult worms 
were then transferred in fresh media containing treatment every 48 hours. Mfs and L4s 
were also checked for motility and if highly active they were treated with desired 
treatment. Additional 100 pL with or without treatment was added with the final desired 
concentration of the drug for mfs.
Motility of female adults, mf, and L4 were observed every 24 hours and score 
from 0 to 4 was given. All data for female adults and other stages were analyzed by a 
one sided Student’s /-test using Microsoft Excel. All experiments were repeated at least 
2 times with similar results.
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2.2. MTT Viability Assay
Viability of adult worms was measured colorimetrically using 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma Aldrich, St. Louis, 
MO), which was reconstituted in PBS (13). Parasites were transferred into 96-well plate; 
one worm per well containing 180 pL of PBS. Additionally, 20 pL of a MTT solution 
was added for the final concentration of 5 mg/mL. The plate was incubated for 30 min at 
37°C. All solutions were removed and 200 pL of DMSO was added to each well. The 
plate was incubated for another 30 min at 37°C. Using a Synergy2 Microplate reader 
(BioTek, Winooski, VT), absorbance was measured at 550 nm.
3. Generation o f bm-JNKl expression vectors
Bm-JNKl sequence was obtained from UniProt protein database (accession no. 
A8Q111), and synthetically produced in pDONR™221 by Genscript (Piscataway, NJ). 
The bm-JNKl sequence was human optimized. The pDONR™221 containing the bm- 
JNKl gene was recombined into a mammalian expression system (pDEST™27) and 
bacterial (Escherichia coli) expression system (pDEST™15 and pDEST™17) using an in 
vitro EE recombination (Invitrogen) reaction following the manufacturer’s instructions. 
The LR recombination reaction produced bm-JNKl/pDEST™X (X = 15, 17, or 27). The 
pDEST™27 and pDEST™15 vector has Glutathione S-transferase (GST) fusion tag at 
N-terminal. The pDEST™17 vector has hexa histidine (6xHis) fusion tag at the N- 
terminal. The plasmid concentration of bm-JNKl /ipDEST™X was determined using 
NanoDrop (Thermo-Scientific, Wilmington, DE).
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4. Bacterial expression o f recombinant Bm-JNK1
Bm-JNKl/pDEST15 or Bm-JNKl/pDEST17 was transformed into BL21-A1™ 
One Shot® (Invitrogen) using the manufacturer’s instructions. The transformed cells were 
plated onto 100 pg/mL carbenicillin agar plate. The plate was placed in a 37°C incubator 
overnight. Next day, a starter culture (10-25 mL) containing LB broth (Invitrogen) 
supplemented with 100 pg/mL carbenicillin was inoculated. The culture was grown in a 
37°C incubator with aeration shaking at 200 rpm overnight. A large culture was 
inoculated containing LB broth supplemented with 100 pg/mL carbenicillin using the 
starter culture with 1:20 dilution. The large culture was grown in the 37°C incubator with 
aeration shaking at 200 rpm for 3 h. After 3 h, the culture was induced with final 
concentration of 0.2% L-arabinose for 5 h. After 5 h, the cells were pelleted at 5000 x g 
for 10 min by centrifugation. The cells were lysed using 4 mL of cold B-PER® (Bacterial 
Protein Extraction Reagent, Thermo-Fisher Scientific) per 1 g of wet cell pellet 
supplemented with 1:100 Halt™ Protease Inhibitor Cocktail (Thermo-Fisher Scientific). 
The cell debris was pelleted at 15,000 x g for 15 min. The negative control was prepared 
as stated above omitting the induction by L-arabinose.
5. Mammalian Expression o f recombinant Bm-JNKl
FreeStyle™ 293-F cells (HEK 293F, Invitrogen) were maintained in a 37°C 
humidified incubator on a shaker (Thermo-Scientific MaxQ 2000 CO2) at 135 rpm with 
8% CO2. Cells were sustained in FreeStyle™ 293 expression medium (Invitrogen) in 
either 125, 250, or 500 mL polycarbonate Erlenmeyer flasks (Fisherbrand). On the day
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of transfection, cells were subcultured at 1 x 106 cells/mL with 90% or higher viability. 
Cells density and viability was determined using tryphan blue exclusion method (14). 
Cells were transfected with either bm-JNKl/pDEST™27 expression vector using the 
FreeStyle™ MAX Reagent (Invitrogen) for 48 h following the manufacturer’s 
instructions. In order to activate Bm-JNKl, cells were treated with 400 pM sodium 
arsenate 3 h prior to protein extraction. Transfected cells were centrifuged at 100 x g for 
10 minutes. The cells are then washed with cold phosphate buffered saline (PBS) and 
centrifuged at 100 x g for 10 minutes. The cells were lysed using 1 mL of M-PER® 
(Mammalian Protein Extraction Reagent, Thermo-Fisher Scientific) per 100 mg of wet 
cell pellet supplemented with 1:100 Halt™ Protease Inhibitor Cocktail (Thermo-Fisher 
Scientific). The lysis solution was centrifuged at 14,000 x g for 10 minutes prior to use.
6. Purification o f Bm-JNKl
A small column with 0.5 mL HighAffinity GST Resin (Genscript, Piscataway, 
NJ) was used to purify Bm-JNKl with GST tag (bacterial or mammalian). The 
purification was performed at 4 °C. Column was equilibrated with PBS using 10 times 
the resin volume. The crude extract was resuspended with the resin and incubated on a 
tube rotator for an hour. The flowthrough was collected followed by four 2 mL PBS 
washes. The fifth wash was washed with elution buffer (25 mM HEPES, 150 mM NaCl, 
1 mM DTT, 10% glycerol, 0.1 mM EDTA, 1:100 Halt™ Protease Inhibitor Cocktail). 
Proteins were eluted with elution buffer supplemented with 10 mM reduced L- 
glutathione (Sigma-Aldrich) using the same volume as the resin bed volume. Proteins
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concentrations were determined using the Bradford assay (Sigma-Aldrich), according to 
the manufacturer’s instructions. Bovine serum albumin (BSA) was used as a standard.
HisPur™ Cobalt Purification Kit (Thermo Scientific) was used to purify Bm- 
JNK1 with His tag (bacterial) following the manufacturer’s instructions.
7. SDS-PAGE and Western Blot o f Bm-JNKl protein
Bm-JNKl GST or his tagged was evaluated with sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot. The SDS-PAGE gel 
samples were prepared using 65 % of protein sample and 35 % of master mix including 
25 % NuPAGE SDS sample buffer (Invitrogen) and 10 % DTT reducing agent. Samples 
were heated on heating block at 90 °C for 5 minutes. Novex sharp pre-stained protein 
standard (Invitrogen) was used as molecular weight markers. Samples were run in a 10- 
well NuPAGE 4-12% Bis-Tris gel (Invitrogen) at 200V for 40 minutes. Gel was stained 
for 1 hour in staining solution (0.05% Coomassie Blue, 10 % acetic acid and 44% 
methanol), followed by 30 minutes fixing (50% methanol and 10% acetic acid) and 1 
hour destaining (5% acetic acid).
In order to perform Western blot, SDS-PAGE was performed as stated earlier 
using MagicMark™ XP Western Standard (Invitrogen) as molecular weight markers. 
SDS-PAGE was transferred onto polyvinylidefluoride (PVDF) membrane using TE77XP 
Semi-Dry Blottter (Hoefer, Holliston, MA) and NuPAGE® transfer buffer (Invitrogen) 
containing 10 % methanol and 0.25% SDS. The blot was transferred for 1 h at 54 mA 
per blot. In order to prevent non-specific binding, membrane was placed in blocking
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solution (5% non-fat dry milk in Tris-buffered saline and 0.05% Tween® 20 (TBST)) for 
one hour.
The membrane was incubated with 1:1000 goat anti-GST polyclonal IgG primary 
antibody (GE Healthcare, Piscataway, NJ) or 1:1000 mouse anti-His monoclonal IgG 
primary antibody (EMD Millipore, Billerica, MA) for Bm-JNKl GST or His tag 
respectively. Both antibodies were prepared in TBST containing 1.0 mg/mL BSA and 
0.01% sodium azide. The membrane was incubated with primary antibody for 1 h in 
room temperature or overnight at 4°C. Membrane was washed three times with TBST at 
5 minutes intervals followed by 30 minutes incubation with alkaline phosphatase (AP)- 
linked secondary antibody. The secondary antibody used were 1:5000 mouse anti-goat 
polyclonal IgG (Santa Cruz Biotechnology, Santa Cruz, CA) or 1:7500 dilution goat anti­
mouse (Promega, Madison, WI) for Bm-JNKl GST or His tag respectively. After 30 
minutes, membrane was washed 2 times with TBST for five minutes, followed by one 
wash with water for 5 min. The membrane was developed using 2 mL of Western Blue® 
Stabilized Substrate for Alkaline Phosphatase (Promega). The reaction was stopped with 
water after the bands showed up.
8. Bm-JNKl kinase assays 
8.1. ADP-Glo™Kinase Assay
ADP-Glo™ Kinase Assay (Promega) is high-throughput luminescent based assay to 
measure kinase activity by quantifying the amount of ADP produced during an kinase 
reaction. This assay is a two-step process; first is the addition of ADP-Glo™ Reagent
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(AGR) and second is the addition Kinase Detection Reagent (KDR). The kinase reaction 
was incubated for 1 h using 100 pg/mL myelin basic protein (MBP) as substrate. After 1 
h, the kinase reaction was terminated and the remaining ATP was depleted with the 
addition of AGR. The KDR was added to convert ADP to ATP and to allow the newly 
synthesized ATP to be measured using a luciferase reaction. ATP to ADP conversion 
curve is used to correlate the ADP concentration. The assay was performed using the 
manufactures procedures. The luminescence signal was read using Synergy 2 Microplate 
reader.
8.2. IMAP Assay
The Immobilized metal ion affinity-based fluorescence polarization (IMAP) assay 
(Molecular Devices) was used to assess the activity of Bm-JNKl. The kinase activity is 
detected by high-affinity interactions of trivalent metal containing nanoparticles with 
phosphogroups on either serines, threonines or tyrosine. The kinase reaction was 
initiated using Bm-JNKl using FI-EGFR substrate. The reaction was incubated for 1 h 
and the nanoparticles was added. The assay was performed using the manufacturer’s 
procedures. The fluorescence polarization was read in parallel and perpendicular with 
excitation wavelength of 485 nm and emission wavelength 528 nm. The plate was read 




In the parasitic nematode B. malayi, one isoform of JNK was found which we termed 
Bm-JNKl. In comparison to other JNK sequences from other parasitic nematodes such as W. 
bancrofti and Loa Loa, as well as the non-parasitic nematode, C. elegans and humans, there is 
high homology at the Threonine-Proline-Tyrosine (TPY, Figure 1) dual phosphorylation 
activation siter Interestingly, Bm-JNKl contains a 86 amino acid sequence insert not found in C. 
elegans or Humans. This insert may confer properties useful for finding selective inhibitors.
Effects o f JNK inhibitors on B. malayi motility and viability
Based on the fact that JNK does exist in B. malayi, three different human JNK inhibitors 
were used to examine whether Bm-JNKl plays a role in protecting B. malayi from heavy metal 
and oxidative stress. The JNK inhibitors used were JNKi, SP600125, and TCS.
Adult worms were treated with control 0.1 % DMSO, 25 pM copper sulfate (CuS04) and 
10 pM JNKi inhibitor alone or in combination with 25 pM CuS04. There is minimum or no 
effect on the parasite motility with 10 pM JNKi inhibitor or 25 pM CuS04 alone when compared 
to the control. However, there is a drastic decrease in motility with combination of JNKi 
inhibitor and copper sulfate. On the third day, there was approximately 77-81% inhibition of the 
motility in the comparison with 25 pM CuS04or 10 pM JNKi alone (Figure 2).
In order to determine if motility correlates with the viability of the parasite, an MTT 
assay was performed. The MTT assay showed a significant decrease in viability for 10 pM JNKI 
inhibitor in combination with 10 pM copper sulfate in 3 days (Figure 3). These MTT results 
indicate that motility is good measure of the viability of the parasites. These results support the
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notion that Bm-JNKl, like the C. elegans JNK ortholog, plays a role in protecting B. malayi from 
heavy metal stresses.
As mention before, current treatments are only effective on microfilariae so its important 
to find a target/ treatment that will be effective on all stages of the parasites, especially adults. In 
order to establish if Bm-JNKl plays a role in protecting other forms of the parasite from heavy 
metal stress, two additional stages were evaluated. The first was the L4 larval form. L4 is the 
larval form of the parasite that mature to adult worms in the host. The L4s were treated with 0.1 
% DMSO, 10 pM copper sulfate, 10 pM JNKi inhibitor alone and in the presence of 10 pM 
copper sulfate. There is minimum effect on the motility with 10 pM copper sulfate or 10 pM 
JNKi compared to 0.1% DMSO, but in combination of those two there is drastic decrease in 
motility (Figure 4). On the third day, L4 were completely dead with combined treatment with 10 
pM copper sulfate and 10 pM JNKi. These results indicate that that Bm-JNKl is also involved in 
the protection of L4s from heavy metal stress.
Lastly, the effect of JNK inhibitors on heavy metal stress pathways in mf was evaluated. 
Mfs were treated with 3 JNK inhibitors, 10 pM JNKi, 1 pM SP600125 and 10 pM TCS, under 
two different stresses heavy metal stress and oxidative stress. There is minimum or no effect with 
JNK inhibitors alone or the stress, heavy metal or oxidative stress, alone compared to the control. 
The combination of three JNK inhibitors under either stress showed there is a significant decrease 
in motility of microfilariae (Figure 5). The microfilariae showed a significant decrease in motility 
with three inhibitors in combination with heavy metal stress compared to arsenate induced 
oxidative stress. It is known that Cu2+, like arsenate, can lead to ROS production, but the relative 
amounts of ROS produced are not known. This may explain the effects with arsenate on mf.
13
Expression and purification o f recombinant Bm-JNKl
Bm-JNKl kinase, an ortholog of human and C. elegans JNK, was successfully expressed 
in bacterial and mammalian cells; the protein analysis was done using SDS-PAGE and Western 
blotting. The His-tagged recombinant Bm-JNKl did not express in the bacterial system. 
However, a GST-tagged recombinant protein was successfully expressed using the bacterial 
expression system. The Western blot as well as staining gel revealed a faint band at 89 kDa as 
expected. Bm-JNKl is 62 kDa plus additional 27 kDa for GST-fusion tag (Figure 6). The 
Western blot also revealed a band at 27 kDa in the flow through and all 5 eluted fractions. This 
may indicate proteolytic cleavage of the GST tag.
Due to the fact that there was minimum amount of recombinant protein obtained from 
bacterial expression, Bm-JNKl was further expressed in mammalian cells. HEK 293-F cells were 
transfected with the Bm-JNKl/pDEST27™ expression vector. The pDEST27™ produced a 
GST-tagged Bm-JNKl. Protein expression was analyzed by SDS-PAGE and Western blotting 
(Figure 7).
Enzymatic activity o f Bm-JNKl
Bm-JNKl with GST in bacterial cells and in mammalian cells
In order to determine the activity of the Bm-JNKl-GST, an Immobilized metal ion 
affinity-based fluorescence polarization (IMAP) assay and ADP-Glo assay was performed. An 
IMAP assay was used to determine the activity of the Bm-JNKl GST tagged expressed in 
bacteria. The assay showed that there was no activity Bm-JNKl GST tagged which was expected. 
Additionally, Bm-JNKl GST tagged was activated by upstream activator MKK7 unfortunately 
even with the MKK7 activation there was no activity. The unsuccessful activation of Bm-JNKl-
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GST could be resulted from the fact that there is hundred amino acid insert in the Bm-JNKl in
turn Bm-JNKl is not recognizing the human MKK7.
Bm-JNKl with GST in bacterial cells and in mammalian cells
Moreover, its been previously demonstrated that recombinant human JNK expressed in 
mammalian cells is not active, but it can be activated in situ by treatment with sodium arsenate. 
Using the same approach, Bm-JNKl-GST was transfected with Freestyle 293-F cells that were 
treated with 400 pM sodium arsenate 3 hours prior to harvesting the cells. Bm-JNKl was affinity 
purified and the kinase activity was evaluated using IMAP or ADP-Glo assay. As expected there 
was no kinase activity for unstressed Bm-JNK GST tagged with neither assay. Unexpectedly, 
IMAP and ADP-Glo assay reveled that stressed-activated Bm-JNKl GST tagged had no activity. 
Furthermore, no activity of Bm-JNKl GST tagged could be due to the GST-tag interference with 
the substrate. Moreover, as mention previously due to the fact that Bm-JNKl has hundred amino 
acid insert, the substrate of either assay could not recognize it.
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Discussion
B. malayi is one of the causes of lymphatic filariasis which is highly disfiguring disease 
where there is limited treatment options. Current drugs are not effective against adult worms, 
which are needed to terminate the lifecycle of lymphatic filariasis. I have studied a B. malayi 
ortholog of human and C. elegans JNK, termed Bm-JNKl. Bm-JNKl is highly homologous at 
the activation site to C. elegans where is known to play a critical role in protecting the parasite 
against heavy metal stress, as well as oxidative stress.
I have demonstrated, a conserved role for B. malayi Bm-JNKl in protection against 
heavy metal stress against both adult and mf forms of the parasite. I have shown that treatment of 
adults and mf with JNK inhibitors, under heavy metal stress, results in decrease in motility and 
hence the viability of the parasite.
Additionally, I have successfully expressed recombinant Bm-JNKl in Freestyle 293-F 
cell and in bacterial cells. Although, both assays did not show any Bm-JNKl activity this may be 
due to several reasons. There is an additional 86 amino acid insert in the Bm-JNKl sequence 
which is not present in human and C. elegans JNK indicating that the conformation of the 
enzyme might be much different than human and C. elegans. This could lead to alter substrate 
recognition as well as novel upstream activation mechanism. Moreover, the 27 kDa GST tag 
could potentially be interfering with substrate binding. These results demonstrate a conserved 
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-------------------------------- ---- - VBVWSIGCIFGELIRGRVLFPGGDHIDQ 326
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Figure 1. Clustal W Alignment of a fragment of c-Jun N-terminal kinase including (from the top) 
B. malayi, W. bancrofti, Loa Loa, C. elegans and human. The similarities are highlighted in gray, 
the activation site is highlighted in red and the additional hundred amino acid insert, in parasitic 
nematodes, is highlighted in yellow.
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Figure 2. Effect of heavy metal-induced stress on adult female B. malayi motility in the presence 
or absence of JNKi. Female adult worms were cultured with the indicated treatment in a 24-well 
plate. Adult worm motility was observed every 24 h and a score 0-4 was given. * p<0.0001 by a 
one-tailed unpaired Student’s r-test using copper sulfate (CuS04or Cu2+) as a vehicle control for 
the combination of copper sulfate and JNKi and 0.1% DMSO as a vehicle control for JNKi and 
copper sulfate alone, n = 4 or 5 female adult worms. Bars represent mean ± standard errror (SE).
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Figure 3. Effects of heavy metal-induced stress on adult female B. malayi viability in the presence 
or absence of JNKi assessed by MTT assay on day 3. Female adult worms were cultured with the 
indicated treatment in a 24-well plate. * p<0.0001 by a one-tailed unpaired Student’s /-test using 
0.1% DMSO as a vehicle control for the treatments, n = 4 or 5 female adult worms. Bars 
represent mean + standard error (SE).
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Figure 4. Effects of copper induced heavy metal stress on B. malayi L4 motility in the presence 
or absence of JNKi. L4 were cultured with the indicated treatment in a 4-5 L4 in well in 24-well 
plate. L4s were observed every 24 h and a score 0-4 was given. *p<0.001, **p<0.0001 by a one- 
tailed unpaired Student’s ¿-test using copper sulfate (CuS04or Cu2+) as a vehicle control for the 
combination of copper sulfate and JNKi and 0.1% DMSO as a vehicle control for JNKi and 
copper sulfate alone, n — 4 or 5 female adult worms. Bars represent mean + standard errror (SE)
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A. Copper induced Heavy Metal stress B. Arsenate induced oxidative stress
Figure 5. Effects of copper-induced heavy metal stress (A) and arsenate-induced oxidative stress 
(B) on B. malayi mf motility in the presence or absence of indicated treatment. Mf were cultured 
with the indicated treatments in a 96-well plate. Mf motility was observed every 24 h and a score 
0-4 was given. * p<0.001, ** p<0.0001 by a one-tailed unpaired Student’s /-test using stress 
(Cu2+or As) as a vehicle control for the combination of stress (Cu2+or As) and indicated JNK 
inhibitors and 0.1% DMSO as a vehicle control for indicated JNK inhibitors and copper sulfate 












Figure 6. Purification of GST tagged Bm-JNK1 from bacterial cells. The lane correspond to the 
following; lane 1: molecular weight markers, lane 2: purified GST (Positive Control), lane 4: Bm- 
JNK-GST -  Crude extract, lane 4: Bm-JNK-GST - Flow through, lane 5: Bm-JNK-GST - Wash 
1, lane 6: Bm-JNK-GST - Wash 5, lane 7: Bm-JNK-GST -  Eluent 1, lane 8: Bm-JNK-GST -  
Eluent 2, lane 9: Bm-JNK-GST -  Eluent 3, and lane 10: Bm-JNK-GST -  Eluent 4. On the left: 
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Figure 7 . Purification of Bm-JNK-GST from mammalian cells. The lane correspond to the 
following; lane 1: molecular weight markers, lane 2: JNK1-GST (Positive Control), lane 3: Bm- 
JNK-GST -  Crude Extract, lane 4: Bm-JNK-GST - Flow through, lane 5: Bm-JNK-GST - Wash 
1, lane 6: Bm-JNK-GST - Wash 2, lane 7: Bm-JNK-GST -  Wash-5, lane 7: Bm-JNK-GST -  
Eluent 2, lane 8: Bm-JNK-GST -  Eluent 3, lane 9: Bm-JNK-GST — Eluent 4, lane 10: Bm-JNK- 
GST -  Eluent 5. On the left: Coomassie Blue stained 4-12% Bis-Tris gel. On the right: Western 
blot. Coomassie Blue stained 4-12% Bis-Tris gel.
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